trending Market Intelligence /marketintelligence/en/news-insights/trending/4f89frfu_oi1iscgjurpkw2 content esgSubNav
In This List

PolarityTE acquires biomedical research facility

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021


PolarityTE acquires biomedical research facility

PolarityTE Inc. acquired a preclinical biomedical research facility to develop its pipeline products.

The facility, a contract research organization, is fully functional and compliant with the Good Laboratory Practices and United States Department of Agriculture standards, the biotechnology company said.

The CEO and chairman of the company, Denver Lough, said "the purchase … integrates a new arm of the company — PolarityRD — which will function as an advanced CRO to help drive the field of biotechnology to deliver on the promise of exciting emerging technology."

The Salt Lake City-based biotech is developing a range of regenerative tissue products and biomaterials for use in medicine, biomedical engineering and material sciences.